IP Verse

Intranasal Epinephrine Formulations And Methods For The Treatment Of Disease - EP3678649

PATENT ANALYSIS

Patent Details

Grant Date
Dec 21, 2022
Company
AEGIS THERAPEUTICS, LLC
Oppositions

AERA A/S

More patents of Aegis Therapeutics, Llc

EP3678649

Want to monitor this patent?

Feel free to send us a message here and we will get back to you